ScreenPoint Medical’s Transpara AI has analyzed 5 million mammograms and 1 million Tomosynthesis studies, spotlighting at RSNA 2023. Studies reveal its role as a ‘second pair’ of eyes aiding cancer detection, and reducing recall…
Continue Reading
iCAD and CancerIQ have united to create an advanced breast healthcare solution. Their partnership merges iCAD’s AI-driven ProFound Breast Health Suite with CancerIQ’s precision platform, enhancing breast cancer risk prediction and personalized care plans….
Continue Reading
AI’s impact on healthcare unfolds through HEALWELL AI’s acquisition of Pentavere, fortifying data-driven diagnostics. Forward Health introduces CarePods, reshaping accessibility to comprehensive medical services. Lunit’s FDA clearance for breast cancer detection highlights AI’s pivotal…
Continue Reading
What You Should Know:
SciBase Holding AB, a developer of augmented intelligence-based solutions for skin disorders, has entered into a collaboration agreement with the Skin and Cancer Institute to pilot Nevisense in several of their…
Continue Reading
The RSNA Margulis Award-winning study introduces a game-changing AI-driven tool for pancreatic cancer detection on CT scans. Led by Po-Ting Chen, M.D., and the team, the research showcases the tool’s 90% sensitivity and 93%…
Continue Reading
Dr. Robert Bard, a leader in radiological diagnostics, advocates for 3D Doppler imaging’s role in non-invasive cancer detection, particularly in breast, prostate, and skin cancers. Highlighting its precision and the reduced need for biopsies,…
Continue Reading
Paige, a global leader in digital pathology solutions, has received the FDA’s Breakthrough Device Designation for Paige Lymph Node. This AI application is a pioneering tool for detecting breast cancer metastases in lymph nodes….
Continue Reading
Teri Thomas, CEO and Managing Director at Volpara Health
Breast cancer awareness is essential for early detection, which is critical for improving survival rates and reducing the burden of this disease. October is Breast Cancer…
Continue Reading
Lunit and Leeds Teaching Hospitals NHS Trust are launching the world’s first prospective study of AI-powered breast screening in symptomatic clinics, using Lunit INSIGHT MMG. This innovative initiative aims to improve breast cancer detection,…
Continue Reading
Cancer detection technology startup Adela announced it secured $48 million in funding, bringing its total raise to $108 million. Labcorp joined the round as a new investor alongside existing investors OrbiMed, Decheng Capital, F-Prime Capital,…
Continue Reading
